Top Abstract Purchase Related
Home
>
Node
>
Subnode

Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group

Sutter, V.L.; Kwok, Y.Y.

Antimicrobial Agents and Chemotherapy 20(6): 723-725

1981

ISSN/ISBN: 0066-4804
PMID: 6459765
Document Number: 173346
The in vitro activity of cefoperazone against 32 strains of bacteria of the B. fragilis group was determined on 4 media by using a variety of test parameters. Lower mean minimal inhibitory concentrations (MIC) were obtained on Mueller-Hinton blood agar and supplemented brain heart infusion agar than were obtained on brucella laked blood agar or Wilkins-Chalgren agar. Higher MIC were obtained with 6-h inocula than with 24-h inocula and slightly higher MIC were obtained with tests read at 48 h as compared with 24 h. Conducting tests in an anaerobic glove box had little effect. The greatest differences in mean MIC were seen with inoculum densities of 104 and 105 colony forming units.

Document emailed within 1 workday
Secure & encrypted payments

Castillo, A.M.; Fernández-Crehuet, M.; Ocete, M.D.; Liébana, J.J.; Cueto, A.; Maroto, M.C.; Piédrola, M.G. 1986: Comparative in vitro activity of 4 cephalosporins on Bacteroides fragilis Medicina Clinica 86(15): 624-626
Bazhenov, L.G. 1990: Isolation and identification of Bacteroides of the group B. fragilis Laboratornoe Delo 4: 9-13
Siverhus, D.J.; Edmiston, C.E.; Clausz, J.C.; Goheen, M.P. 1988: Post-antibiotic effect in Bacteroides fragilis group Annals of Clinical and Laboratory Science 18(4): 326-336
Bideberry, D.; Lesage, D.; Petit, J.C.; Daguet, G.L. 1980: Detection of the Bacteroides fragilis group in clinical specimens by indirect immunofluorescence La Nouvelle Presse Medicale 9(30): 2080-2081
Hansen, S.L.; Swomley, P.; Drusano, G. 1981: Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin Antimicrobial Agents and Chemotherapy 19(2): 335-336
Wexler, H.M.; Finegold, S.M. 1991: Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group Journal of ChemoTherapy 3(Suppl 2): 12-19
Reinhold, L. 1971: Serological investigations on strains of Bacteroides thetaiotaomicron and Bacteroides fragilis using the agargel precipitation technique Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie Virusforschung und Parasitologie. Originale 216(2): 219-227
Miyazaki, S.; Ishii, T.; Tsuji, A.; Kitaya, S.; Kaneko, Y.; Ogawa, M.; Goto, S. 1986: Pathogenic factors in mixed infection due to Bacteroides fragilis and other species of bacteria in mice Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 41(3): 611-617
Rokosz, A.; Meisel-Mikołajczyk, F.; Kot, K.; Zawidzka, E.; Malchar, C.; Nowaczyk, M.; Górski, A. 1999: Toxins of Bacteroides fragilis and Bacteroides thetaiotaomicron rods as stimulators of adhesion molecule expression on the surface of vascular endothelial cells Medycyna Doswiadczalna i Mikrobiologia 51(1-2): 133-142
Martin, M.A.; Liebana, J.; Castillo, A.M.; Gutierrez, J.; Piédrola, G. 1991: A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis Microbios 67: 272-273
Magnuson, D.K.; Weintraub, A.; Pohlman, T.H.; Maier, R.V. 1989: Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide Journal of Immunology 143(9): 3025-3030
Houvenaeghel, M.; de Moro, S.; Ottomani, A.; Bedos, B.; Lallemand, J.; Manelli, J.C.; Bimar, J. 1986: Bacteroides fragilis meningitis. 2 cases Presse Medicale 15(33): 1669-1672
Montejo Baranda, M.; Gonzalez de Zarate Apiñamiz, P.; Barron Fernandez, J.; Aguirre Errasti, C. 1984: Meningitis caused by Bacteroides fragilis Canadian Medical Association Journal 131(3): 184 186
Miyamae, S.; Nikaido, H.; Tanaka, Y.; Yoshimura, F. 1998: Active efflux of norfloxacin by Bacteroides fragilis Antimicrobial Agents and ChemoTherapy 42(8): 2119-2121
Niyogi, S.K.; Dutta, P.; Mitra, U.; Pal, D.K. 1997: Association of enterotoxigenic Bacteroides fragilis with childhood diarrhoea Indian Journal of Medical Research 105: 167-169
Watanabe, K.; Kobayashi, T.; Imamura, H.; Mochizuki, I.; Ezaki, T.; Kobata, S.; Ninomiya, K.; Ueno, K.; Suzuki, S. 1978: Synergistic effect of ampicillin and dicloxacillin against Bacteroides fragilis Japanese Journal of Antibiotics 31(1): 1-4
García Rodríguez, J.A.; García Sánchez, J.E.; Gómez Garciá, A.C.; Prieto Prieto, J. 1977: Evaluation of the disc-plate method in Bacteroides fragilis Revista Clinica Espanola 146(3-4): 161-166
Cadoz, M.; Beucler, A.; Dublanchet, A.; Richard, A.; Deborne, B.; Lafaix, C. 1978: Bacteroides fragilis bacteremias: clinical and evolutive features about 33 cases La Nouvelle Presse Medicale 7(23): 2045-2048
Zhou, Z.; Fan, X.; Feng, P.; Lü, X.; Lin, J.; Zhang, H.; Lu, Y. 1997: Molecular cloning of the imipenem resistant gene in bacteroides fragilis Hua Xi Yi Ke Da Xue Xue Bao 28(2): 184-187
Clark, D.G.; Schweizer, R.T. 1980: Use of antibiotics for prevention of Bacteroides fragilis wound sepsis in rats American Surgeon 46(3): 180-183